Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study.
Roberti R, Di Gennaro G, Anzellotti F, Arnaldi D, Belcastro V, Beretta S, Boero G, Bonanni P, Canafoglia L, D'Aniello A, Dainese F, De Caro C, Di Gennaro G, Di Giacomo R, DiFrancesco JC, Dono F, Falcicchio G, Ferlazzo E, Foschi N, Franciotta S, Gambardella A, Giordano A, Iannone LF, Labate A, La Neve A, Lattanzi S, Leggio U, Liguori C, Maschio M, Nilo A, Operto FF, Pascarella A, Pauletto G, Renna R, Strigaro G; COMPARE Study Group; Russo E. Roberti R, et al. Among authors: boero g. Epilepsia. 2024 Feb;65(2):456-472. doi: 10.1111/epi.17843. Epub 2023 Dec 16. Epilepsia. 2024. PMID: 38052481
Current safety concerns about the use of antiseizure medications in pregnancy.
Falcicchio G, Russo E, Fabiano A, Scalese M, Boero G, Trojano M, de Tommaso M, La Neve A. Falcicchio G, et al. Among authors: boero g. Expert Opin Drug Saf. 2022 Dec;21(12):1459-1468. doi: 10.1080/14740338.2022.2160443. Epub 2022 Dec 22. Expert Opin Drug Saf. 2022. PMID: 36537559 Review.
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy.
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST (Brivaracetam Add‐On First Italian Network Study) Group Membership. Lattanzi S, et al. Epilepsia. 2023 Nov;64(11):2922-2933. doi: 10.1111/epi.17740. Epub 2023 Sep 9. Epilepsia. 2023. PMID: 38079181 Free article.
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?
Cerulli Irelli E, Cocchi E, Mostacci B, Orlando B, Gesche J, Caraballo RH, Lattanzi S, Strigaro G, Catania C, Pulitano P, Panzini C, Ferlazzo E, Pascarella A, Casciato S, Pizzanelli C, Giuliano L, Viola V, Fortunato F, Di Gennaro G, Gambardella A, Labate A, Operto FF, Giallonardo AT, Baykan B, Beier CP, Di Bonaventura C; Women With Epilepsy Treatment Options and Research Study Group. Cerulli Irelli E, et al. Epilepsia. 2024 Mar;65(3):e27-e34. doi: 10.1111/epi.17892. Epub 2024 Jan 31. Epilepsia. 2024. PMID: 38294338
Conversion to Brivaracetam Monotherapy in Clinical Practice: A Retrospective Study.
Lattanzi S, Foschi N, Martellino C, Audenino D, Boero G, Bonanni P, Ferlazzo E, Chiesa V, Dainese F, Piccioli M, Ferrari A, Labate A. Lattanzi S, et al. Among authors: boero g. Neurol Ther. 2024 Apr;13(2):389-398. doi: 10.1007/s40120-024-00580-2. Epub 2024 Feb 1. Neurol Ther. 2024. PMID: 38300459 Free PMC article.
130 results